Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: Prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization

Archives of Dermatology

Volumn 148, Issue 1, 2012, Pages 128-130

  Moore, Rachael L ^a,b   De Schaetzen, Virginie ^c   Joseph, Marissa ^d   Lee, Ivy Ann ^e   Miller Monthrope, Yvette ^d   Phelps, B Ryan ^f   Lekalake, Shimane S ^f   Ratcliffe, Sarah J ^g   Nguyen, Harrison ⁱ   He, Qin ^h   Rady, Peter ^h   Tyring, Stephen ^h   Kovarik, Carrie L ^g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Presbyterian Intercommunity Hospital   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Princess Marina Hospital   (Botswana)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GLYCOLIC ACID;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SCALING; SCHOOL CHILD; SKIN DISEASE; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADMINISTRATION, TOPICAL; ADOLESCENT; CHILD; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENOTYPE; GLYCOLATES; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES;

EID: 84855996921     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.268     Document Type: Article

References (8)

1. Borbujo J, Olmos O, Zamora E, Diez JJ. Treatment of verrucae plana with 15% glycolic acid. Int J Dermatol. 2000;39(3):236-237. (Pubitemid 30223894)
2. de Villiers EM. Papillomavirus and HPV typing. Clin Dermatol. 1997;15(2):199-206.
3. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27. (Pubitemid 38737395)
4. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315-320.
5. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33(3):690-695.
6. Fuessel Haws AL, He Q, Rady PL, et al. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods. 2004;122(1):87-93. (Pubitemid 39370054)
7. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol. 2003;15(5):382-388. (Pubitemid 37083185)
8. Biraro S, Morison LA, Nakiyingi-Miiro J, Whitworth JA, Grosskurth H. The role of vertical transmission and health care-related factors in HIV infection of children: a community study in rural Uganda. J Acquir Immune Defic Syndr. 2007;44(2):222-228. (Pubitemid 46292226)